Peptide of the Week: Epitalon — 10% Off This Week
Peptide of the Week: Epitalon — 10% Off This Week
Kisspeptin is a naturally occurring peptide signaling molecule that plays a central role in the regulation of the hypothalamic-pituitary-gonadal axis. It acts upstream of gonadotropin-releasing hormone and is studied primarily for its effects on puberty, reproductive endocrinology, ovulatory signaling, gonadotropin release, and fertility-related physiology.
Kisspeptin is one of the most important upstream regulators of reproductive hormone signaling studied in modern endocrinology. In humans, kisspeptin signaling influences GnRH secretion and downstream LH and FSH dynamics, which is why it is heavily studied in puberty, menstrual cyclicity, ovulation, hypothalamic amenorrhea, and assisted reproduction.
The strongest human evidence around kisspeptin is in reproductive endocrinology, not in broad consumer-health claims. Published human studies show acute stimulation of gonadotropin secretion, investigation in hypothalamic amenorrhea, and research use in triggering oocyte maturation during IVF.
Regulatory framing matters. FDA materials state that compounded drugs containing Kisspeptin-10 may pose immunogenicity and peptide-characterization concerns for certain routes of administration, and FDA says it has no or only limited safety-related information for the proposed routes discussed there.
Kisspeptin refers to a family of peptides derived from the KISS1 gene that signal through the KISS1 receptor, also called KISS1R or GPR54. This signaling pathway is widely recognized as a major control point in reproductive neuroendocrinology because it regulates GnRH neuronal activity and thereby helps govern LH and FSH secretion downstream.
In practical research terms, kisspeptin is often described as an upstream reproductive signaling peptide. It is not the same thing as GnRH, LH, FSH, or sex steroids, but it helps regulate the cascade that influences them. That upstream position is exactly why kisspeptin has become such a major research target in puberty and fertility science.
Kisspeptin-10 is the bioactive C-terminal fragment of the larger Kiss1 protein. Its shortened sequence allows for higher receptor affinity and faster onset of action in laboratory settings.
Molecular Formula:
Molecular Weight:
Sequence:
CAS Number: 374675-21-5
PubChem CID: 25240297
Purity: (3rd-party tested)
Recent breakthroughs have identified KNDy neurons (Kisspeptin/Neurokinin B/Dynorphin) in the arcuate nucleus as the true “pulse generator” of the human reproductive system. Kisspeptin-10 is the primary signaling molecule these neurons use to communicate with GnRH neurons.
Understanding where a compound interacts with the HPG axis is crucial for experimental design.
In simple terms: it is a signaling peptide that helps tell the brain when to activate reproductive hormone pathways. Researchers study it because it sits near the top of that control chain, linking hypothalamic signaling to GnRH release and then to downstream gonadotropin output. That makes it highly relevant in research on puberty, ovulation, menstrual function, hypothalamic amenorrhea, and IVF-related oocyte maturation.
Kisspeptin acts on KISS1R-expressing GnRH neurons and helps regulate pulsatile GnRH secretion. In human reproductive physiology, that matters because GnRH pulsatility drives downstream LH and FSH release from the pituitary. Reviews of the field describe kisspeptin as a key neuromodulator of human reproduction and a major component of the GnRH pulse generator framework.
This is also why the peptide is so closely linked to puberty timing and reproductive competence. Human genetic and physiological studies have shown that disruption of the kisspeptin/KISS1R pathway is associated with disorders such as idiopathic hypogonadotropic hypogonadism and, in other contexts, precocious puberty.
Kisspeptin is one of the clearest examples of a peptide with real, well-established biological importance but a narrower and more specific evidence profile than the internet often suggests. The evidence is strongest in reproductive physiology and neuroendocrinology. Recent review literature continues to frame kisspeptin and neurokinin B as central regulators of puberty, adult reproductive function, menstrual cyclicity, and ovulatory signaling.
A 2025 review in Physiological Reviews summarized kisspeptin as playing a key role in puberty, adult reproductive function, menstrual physiology, and ovulation-related biology, while also discussing how this biology has led to interest in diagnostic and therapeutic applications.
This is the core category. Kisspeptin is primarily studied for how it regulates GnRH secretion, LH pulsatility, and reproductive endocrine function. Human reviews consistently describe kisspeptin as a major upstream regulator of the reproductive axis.
Kisspeptin signaling has been heavily studied in puberty because responsiveness to kisspeptin appears linked to the emergence of reproductive endocrine activity. Human and translational literature has tied the kisspeptin/KISS1R pathway to pubertal initiation and to disorders involving impaired or abnormal reproductive-axis activation.
Kisspeptin is also studied in functional hypothalamic amenorrhea because FHA involves impaired pulsatile GnRH release. A 2024 review described hypothalamic kisspeptin neurons as a key component of the GnRH pulse generator and discussed kisspeptin’s therapeutic potential in FHA. Earlier human work showed that subcutaneous kisspeptin-54 acutely stimulated gonadotropin secretion in women with hypothalamic amenorrhea, although chronic administration produced tachyphylaxis.
One of the most clinically developed areas of kisspeptin research is its use as an oocyte maturation trigger in IVF. Published human studies reported that a single injection of kisspeptin-54 induced egg maturation in women undergoing IVF, and later work in women at high risk of OHSS described kisspeptin-54 as a promising approach to effectively and safely trigger oocyte maturation in that context.
There is also emerging human research beyond the classic fertility axis. A randomized clinical trial in men with hypoactive sexual desire disorder reported that kisspeptin administration modulated sexual brain processing and increased penile tumescence and measures of desire/arousal. This is real published research, but it is still much less established than the reproductive endocrinology literature and should be presented as emerging rather than definitive.
The strongest authority angle for a Kisspeptin page is not hype. It is precision. Kisspeptin is a serious endocrine research peptide with an unusually strong mechanistic foundation in human reproductive physiology. Its most robust evidence is in GnRH regulation, gonadotropin release, puberty biology, hypothalamic amenorrhea, and IVF-trigger research.
Think of the reproductive hormone axis as a chain of command.
Kisspeptin -> GnRH -> LH/FSH -> downstream reproductive hormone events
Kisspeptin sits near the top of that chain. It does not replace all downstream hormones. It helps signal the system upstream, which is why researchers use it to study whether the hypothalamic reproductive axis is functioning normally or can be stimulated under controlled conditions.
What the evidence supports well:
Kisspeptin is a major regulator of reproductive neuroendocrine signaling. Human evidence supports its relevance in gonadotropin secretion, hypothalamic amenorrhea research, puberty-related endocrinology, and oocyte maturation in IVF settings.
What the evidence supports more cautiously:
Psychosexual and broader translational applications are being studied, but these areas are newer and should not be framed as settled or general-purpose conclusions.
What the evidence does not justify clearly:
A compliant authority page should not imply that kisspeptin is an approved, established consumer-use therapy for broad outcomes. FDA materials discussing Kisspeptin-10 in compounding highlight limited safety-related information and characterization concerns for proposed routes in that context.
The literature on kisspeptin is much stronger than many niche peptides, but it still has boundaries. A lot of translational interest comes from a highly specific endocrine context, not from broad multi-indication clinical practice. Even where human studies exist, they are usually targeted to defined reproductive questions such as hypothalamic amenorrhea or IVF trigger physiology.
Another practical limitation is regulatory framing. FDA’s public materials regarding compounded Kisspeptin-10 raise issues around immunogenicity, peptide-related impurities, API characterization complexity, and limited safety information for proposed routes of administration.
Peptides in Canada Overview: https://luxaralabs.com/peptides-canada/
Peptides 101: https://luxaralabs.com/peptides101/
Research Standards & Methodology: https://luxaralabs.com/research-standards-methodology/
Purity Standards: https://luxaralabs.com/peptide-purity-standards-canada/
Transparency Hub: https://luxaralabs.com/transparency/
How to Read a COA: https://luxaralabs.com/how-to-read-a-coa/
Peptide Storage & Handling: https://luxaralabs.com/peptide-storage-handling-stability/
Research Use Regulations: https://luxaralabs.com/research-use-regulations-canada/
Peptide FAQ: https://luxaralabs.com/peptide-faq-canada/
Luxara Labs Research Index: https://luxaralabs.com/luxara-labs-research-index/
Kisspeptin Product Page: https://luxaralabs.com/product/kisspeptin/
Kisspeptin is a naturally occurring peptide signaling molecule derived from the KISS1 system that regulates reproductive neuroendocrine signaling upstream of GnRH.
Kisspeptin binds to KISS1R on GnRH-related pathways and helps regulate the pulsatile reproductive signaling that influences LH and FSH secretion downstream.
The strongest areas include puberty, reproductive endocrinology, hypothalamic amenorrhea, ovulatory signaling, and IVF oocyte maturation.
No. Kisspeptin is upstream of GnRH in the reproductive signaling cascade. It helps regulate GnRH neuron activity rather than replacing GnRH itself.
Yes. Human studies and reviews support acute gonadotropin stimulation, investigation in hypothalamic amenorrhea, and use in IVF-related oocyte maturation research.
Peptides in Canada Overview: https://luxaralabs.com/peptides-canada/
Peptides 101: https://luxaralabs.com/peptides101/
Research Standards & Methodology: https://luxaralabs.com/research-standards-methodology/
Purity Standards: https://luxaralabs.com/peptide-purity-standards-canada/
Transparency Hub: https://luxaralabs.com/transparency/
How to Read a COA: https://luxaralabs.com/how-to-read-a-coa/
Peptide Storage & Handling: https://luxaralabs.com/peptide-storage-handling-stability/
Research Use Regulations: https://luxaralabs.com/research-use-regulations-canada/
Peptide FAQ: https://luxaralabs.com/peptide-faq-canada/
Ipamorelin Research Guide: https://luxaralabs.com/ipamorelin-research-canada/
CJC-1295 / Ipamorelin Research Guide: https://luxaralabs.com/cjc-1295-ipamorelin-canada/
Tesamorelin Research Guide: https://luxaralabs.com/tesamorelin-canada/
Thymosin Alpha-1 Research Guide: https://luxaralabs.com/thymosin-alpha-1-canada/
Skorupskaite K, et al. The kisspeptin-GnRH pathway in human reproductive health and disease. PubMed: https://pubmed.ncbi.nlm.nih.gov/24615662/
Gianetti E, et al. Kisspeptin and KISS1R: a critical pathway in the reproductive system. PubMed: https://pubmed.ncbi.nlm.nih.gov/18515314/
Lippincott MF, et al. Kisspeptin Responsiveness Signals Emergence of Reproductive Endocrine Activity: Implications for Human Puberty. PubMed: https://pubmed.ncbi.nlm.nih.gov/27214398/
Jayasena CN, et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. PubMed: https://pubmed.ncbi.nlm.nih.gov/19820030/
Jayasena CN, et al. Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. PubMed: https://pubmed.ncbi.nlm.nih.gov/25036713/
Abbara A, et al. Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of OHSS During IVF Therapy. PubMed: https://pubmed.ncbi.nlm.nih.gov/26192876/
Sharma B, et al. Use of kisspeptin to trigger oocyte maturation during IVF treatment. PubMed: https://pubmed.ncbi.nlm.nih.gov/36147569/
Patel AH, et al. Kisspeptin in functional hypothalamic amenorrhea: Pathophysiology and therapeutic potential. PubMed: https://pubmed.ncbi.nlm.nih.gov/39287750/
Mills EG, et al. Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder. PubMed: https://pubmed.ncbi.nlm.nih.gov/36735255/
Koysombat K, et al. Kisspeptin and neurokinin B: roles in reproductive health. PubMed: https://pubmed.ncbi.nlm.nih.gov/39813600/
FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
Join our list and get an instant 10% discount code — valid for first-time buyers.
